Atlas Trials

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Clinical trial NCT01172964 · COMPLETED

Trial details

NCT number
NCT01172964
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Anaplastic AstrocytomaRecurrent Grade III GliomaRecurrent Grade IV GliomaAdult Anaplastic OligodendrogliomaAdult Brain TumorAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaAdult Mixed GliomaRecurrent Adult Brain TumorAdult Anaplastic OligoastrocytomaRecurrent High Grade Glioma
Start date
2010-08-01
Primary completion
2015-02-11
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.